ACADIA Pharmaceuticals(GB:0A4W)
$26.870.00 (0.00%)
GB:0A4W
ACADIA Pharmaceuticals ownership
$26.87
At close:0.00 (0.00%)
ACADIA Pharmaceuticals (0A4W) Ownership - Who Owns ACADIA Pharmaceuticals?
0 Followers
ACADIA Pharmaceuticals (0A4W) Ownership Overview
- 23.07% Insiders
- 15.64% Mutual Funds
- 2.85% Other Institutional Investors
- 23.60% ETFs
- 34.84% Public Companies and Individual Investors
The ownership structure of ACADIA Pharmaceuticals (GB:0A4W) stock is a mix of institutional, retail, and individual investors. Approximately 42.09% of the company’s stock is owned by Institutional Investors, 23.07% is owned by Insiders, and 34.84% is owned by Public Companies and Individual Investors.
The ownership structure of ACADIA Pharmaceuticals (GB:0A4W) stock is a mix of institutional, retail, and individual investors. Approximately 42.09% of the company’s stock is owned by Institutional Investors, 23.07% is owned by Insiders, and 34.84% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 11, 2025 | James M. Daly | $670,800 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Bridgewater Associates, Lp | $3,690,761 | |
| Dec 31, 2025 | Hussman Strategic Advisors Inc | $3,926,370 | |
| Dec 31, 2025 | Fisher Asset Management Llc | $17,764,473 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Felix Baker | 42,912,904 | Institution | 24.83% | 1,153,069,730 |
| Baker Bros. Advisors Lp | 39,590,339 | Insider | 22.91% | 1,063,792,409 |
| BlackRock, Inc. | 22,515,173 | Institution | 13.03% | 604,982,699 |
| Ishares | 16,297,824 | Institution | 9.43% | 437,922,531 |
| Vanguard | 12,103,456 | Institution | 7.00% | 325,219,863 |
| Vanguard Index Funds | 10,180,549 | Institution | 5.89% | 273,551,352 |
| Spdr | 4,992,392 | Institution | 2.89% | 134,145,573 |
| Dfa | 1,889,513 | Institution | 1.09% | 50,771,214 |
| Fidelity Salem Street Trust | 1,548,123 | Institution | 0.90% | 41,598,065 |
| Dfa Investment Dimensions Group Inc | 1,529,606 | Institution | 0.89% | 41,100,513 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 10,180,549 | Institution | 5.89% | 273,551,352 |
| Fidelity Salem Street Trust | 1,548,123 | Institution | 0.90% | 41,598,065 |
| Dfa Investment Dimensions Group Inc | 1,529,606 | Institution | 0.89% | 41,100,513 |
| Fidelity Concord Street Trust | 1,296,290 | Institution | 0.75% | 34,831,312 |
| Tiaa-cref Funds | 1,047,500 | Institution | 0.61% | 28,146,325 |
| Vanguard Scottsdale Funds | 890,085 | Institution | 0.52% | 23,916,584 |
| Vanguard Horizon Funds | 873,716 | Institution | 0.51% | 23,476,749 |
| Artisan Partners Funds Inc. | 823,219 | Institution | 0.48% | 22,119,895 |
| Vanguard Tax-managed Funds | 812,021 | Institution | 0.47% | 21,819,004 |
| T. Rowe Price Quantitative Management Funds, Inc. | 758,178 | Institution | 0.44% | 20,372,243 |
FAQ
Who Owns ACADIA Pharmaceuticals (GB:0A4W)?
According to the latest TipRanks data, approximately 42.09% of the company's stock is held by institutional investors, 23.07% is held by insiders, and 34.84% is held by public companies and individual investors.
What percentage of ACADIA Pharmaceuticals (GB:0A4W) stock is held by institutional investors?
According to the latest TipRanks data, approximately 42.09% of ACADIA Pharmaceuticals (GB:0A4W) stock is held by institutional investors: 15.64% by mutual funds, 23.60% by ETFs and 2.85% by other institutional investors.
What percentage of ACADIA Pharmaceuticals (GB:0A4W) stock is held by retail investors?
According to the latest TipRanks data, approximately 34.84% of ACADIA Pharmaceuticals (GB:0A4W) stock is held by public companies and individual investors.
Who owns the most shares of ACADIA Pharmaceuticals (GB:0A4W)?
Felix Baker owns the most shares of ACADIA Pharmaceuticals (GB:0A4W).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
